Combination of genomic and population—based approaches to characterize the benefit and risk between non-steroid anti-inflammatory drugs (NSAIDs) and colorectal cancer

博士 === 臺北醫學大學 === 藥學系(碩博士班) === 107

Bibliographic Details
Main Authors:	Chun-Nan Kuo, 郭俊男
Other Authors:	Wei-Chiao Chang
Format:	Others
Language:	en_US
Published:	2019
Online Access:	http://ndltd.ncl.edu.tw/handle/86shsp

id	ndltd-TW-107TMC05551004
record_format	oai_dc
spelling	ndltd-TW-107TMC055510042019-08-09T03:36:20Z http://ndltd.ncl.edu.tw/handle/86shsp Combination of genomic and population—based approaches to characterize the benefit and risk between non-steroid anti-inflammatory drugs (NSAIDs) and colorectal cancer 運用族群資料庫及基因體研究方式探討非類固醇類抗發炎藥與大腸直腸癌之關聯性 Chun-Nan Kuo 郭俊男博士臺北醫學大學藥學系(碩博士班) 107 Wei-Chiao Chang 張偉嶠 2019 學位論文 ; thesis 144 en_US
collection	NDLTD
language	en_US
format	Others
sources	NDLTD
description	博士 === 臺北醫學大學 === 藥學系(碩博士班) === 107
author2	Wei-Chiao Chang
author_facet	Wei-Chiao Chang Chun-Nan Kuo 郭俊男
author	Chun-Nan Kuo 郭俊男
spellingShingle	Chun-Nan Kuo 郭俊男 Combination of genomic and population—based approaches to characterize the benefit and risk between non-steroid anti-inflammatory drugs (NSAIDs) and colorectal cancer
author_sort	Chun-Nan Kuo
title	Combination of genomic and population—based approaches to characterize the benefit and risk between non-steroid anti-inflammatory drugs (NSAIDs) and colorectal cancer
title_short	Combination of genomic and population—based approaches to characterize the benefit and risk between non-steroid anti-inflammatory drugs (NSAIDs) and colorectal cancer
title_full	Combination of genomic and population—based approaches to characterize the benefit and risk between non-steroid anti-inflammatory drugs (NSAIDs) and colorectal cancer
title_fullStr	Combination of genomic and population—based approaches to characterize the benefit and risk between non-steroid anti-inflammatory drugs (NSAIDs) and colorectal cancer
title_full_unstemmed	Combination of genomic and population—based approaches to characterize the benefit and risk between non-steroid anti-inflammatory drugs (NSAIDs) and colorectal cancer
title_sort	combination of genomic and population—based approaches to characterize the benefit and risk between non-steroid anti-inflammatory drugs (nsaids) and colorectal cancer
publishDate	2019
url	http://ndltd.ncl.edu.tw/handle/86shsp
work_keys_str_mv	AT chunnankuo combinationofgenomicandpopulationbasedapproachestocharacterizethebenefitandriskbetweennonsteroidantiinflammatorydrugsnsaidsandcolorectalcancer AT guōjùnnán combinationofgenomicandpopulationbasedapproachestocharacterizethebenefitandriskbetweennonsteroidantiinflammatorydrugsnsaidsandcolorectalcancer AT chunnankuo yùnyòngzúqúnzīliàokùjíjīyīntǐyánjiūfāngshìtàntǎofēilèigùchúnlèikàngfāyányàoyǔdàchángzhíchángáizhīguānliánxìng AT guōjùnnán yùnyòngzúqúnzīliàokùjíjīyīntǐyánjiūfāngshìtàntǎofēilèigùchúnlèikàngfāyányàoyǔdàchángzhíchángáizhīguānliánxìng
_version_	1719233882588446720

Combination of genomic and population—based approaches to characterize the benefit and risk between non-steroid anti-inflammatory drugs (NSAIDs) and colorectal cancer

Similar Items